STEPHANIE HERNDON: Open Payments
NPI 1992797476 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,342 in 110 payments from 21 companies in 2025. Trend: 2023 $1,803 · 2024 $2,810 · 2025 $2,342
Food & beverage: $2,342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $406 |
| Janssen Biotech, Inc. | 16 | $352 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $314 |
| Ardelyx, Inc. | 10 | $182 |
| GENZYME CORPORATION | 6 | $178 |
| Madrigal Pharmaceuticals | 4 | $120 |
| Gilead Sciences, Inc. | 4 | $85 |
| Ipsen Biopharmaceuticals, Inc | 3 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $69 |
Products named: TREMFYA, IBSRELA, DUPIXENT, ENTYVIO, SKYRIZI, RINVOQ, REZDIFFRA, EOHILIA.
Industry payments across VA — which companies pay providers there.
